Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
15.98
-0.12 (-0.75%)
Oct 4, 2024, 4:00 PM EDT - Market closed
Pulse Biosciences Employees
Pulse Biosciences had 56 employees as of December 31, 2023. The number of employees decreased by 5 or -8.20% compared to the previous year.
Employees
56
Change (1Y)
-5
Growth (1Y)
-8.20%
Revenue / Employee
n/a
Profits / Employee
-$786,054
Market Cap
979.42M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
The Pennant Group | 5,791 |
Pediatrix Medical Group | 5,450 |
OPKO Health | 3,930 |
Avanos Medical | 3,771 |
Vir Biotechnology | 587 |
Sana Biotechnology | 328 |
Relay Therapeutics | 323 |
Aurinia Pharmaceuticals | 300 |
PLSE News
- 7 weeks ago - Pulse Biosciences Inc. (PLSE) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results - Business Wire
- 7 weeks ago - Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors - Business Wire
- 2 months ago - Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study with its Nano-PFA Cardiac Surgery System - Business Wire
- 2 months ago - Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences - Business Wire
- 2 months ago - Pulse Biosciences Schedules Second Quarter 2024 Financial Results Conference Call for August 12, 2024 - Business Wire
- 3 months ago - Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for CellFX® nsPFA Cardiac Surgery System for the Treatment of Atrial Fibrillation - Business Wire
- 3 months ago - Pulse Biosciences, Inc. Announces the Closing of its Rights Offering - Business Wire